genedrive is a Manchester-based pharmacogenetic testing company whose products include the MT-RNR1 ID kit. The company focuses on pharmacogenetic diagnostics and commercialisation of its testing products. It plans to accelerate commercial rollout across the UK, Europe and the Middle East. genedrive will also use funds to support clinical studies and regulatory submissions in the US. The company has contracted with a multi-state physician organisation in the US to support the clinical studies required for engagement with the US Food and Drug Administration. Recent fundraising activity is intended to underpin and grow the group’s operations and advance its regulatory and commercial objectives.

Total raised

$7M

Funding rounds

2

Latest round

Equity

Latest activity

May 2024